Este sitio web utiliza tecnologías de seguimiento, como cookies, para brindar una mejor experiencia al usuario. Si continúa utilizando este sitio, entonces reconoce nuestro uso de tecnologías de seguimiento. Para obtener información adicional, consulte nuestra Política de Privacidad.
Merck & Co. has provided multi-year support for Cancer Research Institute patient education programming during Cancer Immunotherapy Month, including sponsorship of the 2017 Fact of the Day social media campaign. Merck has also supported the CRI Irvington Postdoctoral Fellowship Program and provided multi-year support for the Immunotherapy Patient Summit series, including the inaugural Patient Summit. Additionally, Merck has selected CRI as a charity beneficiary of the Your Cancer Game Plan Challenge.
In 2015, Merck’s pioneering leadership in the field of cancer immunotherapy was recognized with the Cancer Research Institute Oliver R. Grace Award, presented to Merck chairman and chief executive officer Kenneth C. Frazier at the Cancer Research Institute Annual Awards Dinner.
*Los resultados de la inmunoterapia pueden variar de un paciente a otro.
Comuníquese con nosotros
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Directorio de Personal
This September for Childhood Cancer Awareness Month, we look at new research, new treatments, and how we are working toward a future immune to childhood cancer.
This September for Gynecologic Cancer Awareness Month, we reflect on new treatments, research discoveries, and how CRI is making its impact on a future immune to cervical, ovarian, and uterine cancers.